As of 2024-07-27, the EV/EBITDA ratio of Intercept Pharmaceuticals Inc (ICPT) is -22.57. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ICPT's latest enterprise value is 915.51 mil USD. ICPT's TTM EBITDA according to its financial statements is -40.56 mil USD. Dividing these 2 quantities gives us the above ICPT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.5x - 9.3x | 7.8x |
| Forward P/E multiples | 5.4x - 12.1x | 9.4x |
| Fair Price | (10.21) - (11.90) | (11.26) |
| Upside | -153.7% - -162.6% | -159.3% |
| Date | EV/EBITDA |